Neoantigen Cancer Vaccines and AI Precision Medicine
Medical Supporter — Information Notice
This article is a summary of international medical information and is not medical advice; it cannot replace the diagnosis or treatment plan of your attending physician. The medical technologies, drug information and clinical data presented here are compiled from public literature and official statements of major Japanese medical institutions; the applicability and outcome of any therapy vary with each patient and must be assessed individually by a qualified physician.
Faced with highly mutated advanced cancers, a single standard treatment is often insufficient. Located in Tokyo’s Minato Ward, the Shirokane Cancer Support Clinic employs a high-end integrated treatment system that combines Artificial Intelligence (AI) with deep genetic sequencing.
1. AI-Guided Genomic Strategy
Using Next-Generation Sequencing (NGS), the clinic scans a patient’s tumor tissue and blood to map the unique landscape of their cancer.
- Precision Drug Matching: Identifies specific genetic mutations to find the most effective targeted therapies.
- Treatment Roadmap: AI analyzes vast databases of expert knowledge and global journals to propose the best adjuvant or post-standard treatment strategies.
2. Personalized Neoantigen Vaccines
This is a truly "tailor-made" approach.
- Antigen Identification: From the patient's unique mutations, the most immunogenic "neoantigens" are selected.
- Synthesis and Administration: These antigens are synthesized into a vaccine and administered to the patient, training the immune system to recognize and eliminate cancer cells carrying those specific mutations. This work is supported by strong clinical research from the University of Tokyo.
3. Comprehensive Combined Approaches
To overcome the "immune suppression" found in advanced cancer patients, Shirokane Clinic implements a multi-pronged strategy:
- Immune Brake-Release: Low-dose chemotherapy or targeted drugs are used to "de-mask" the cancer cells, allowing the vaccine to perform with maximum power.
- Nutrition and Physical Therapy: Supporting cancer recovery through targeted nutrition and muscle maintenance to build the physical strength necessary for long-term treatment.
Medical Advisor: Leading Experts from the University of Tokyo
The clinic’s strategies are advised by Dr. Yasuki Hijikata, head of Palliative Care and Oncology at the Institute of Medical Science, University of Tokyo (IMSUT) Hospital. Dr. Hijikata is one of the few specialists with extensive experience in both cell cultivation and clinical oncology, ensuring that every patient receives a evidence-based, cutting-edge plan.
[Medical Supporter Compliance Statement] Medical Supporter was formerly certified as a medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).
Considering medical care in Japan? Need information and support?
We help you organize the information needed for medical travel to Japan, liaise with Japanese medical institutions, and arrange a second-opinion consultation.The first consultation is free; an advisor will help you clarify the next steps.